COVID
Oorzaak van aanhoudende vermoeidheid bij post-COVID
Post-COVID De meerderheid van de mensen die besmet zijn met het SARS-CoV-2 herstelt binnen enkele weken. Er is echter een kleine groep die post-COVID krijgt. De nasleep van COVID-19 brengt een breed scala aan symptomen met zich mee, maar één symptoom dat steeds vaker naar voren komt, is post-exertionele malaise (PEM). Bij PEM ervaren mensen […]

Aanbevolen

AP/ACS/MI/CVA
Persisterend astma is geassocieerd met plaque in de halsslagader
Astma en atherosclerotische hart- en vaatziekten delen een onderliggende inflammatoire pathofysiologie. Ontsteking speelt een sleutelrol in het ontsta...
Infectieziekten
Antiviraal middel mogelijk toepasbaar voor monkeypox
Monkeypox Humane monkeypox is een zoönose veroorzaakt door het monkeypoxvirus (apenpokkenvirus).1 Het is een orthopoxvirus en daarmee nauw verwa...

Pulmonologie nieuws

[Correspondence] The INSPIRE study: RSV infection during infancy
thelancet.com
The effect of respiratory viral infections (eg, respiratory syncytial virus [RSV] infection, influenza, and COVID-19) in early life on the onset of childhood diseases (eg, asthma, mental health disorders, and childhood cancer) is of great concern globally. However, the challenges facing researchers, paediatricians, and policy makers are a short supply of evidence from well designed observational studies and inconsistent results in randomised controlled trials (RCTs). We were pleased to see that Christian Rosas-Salazar and colleagues1 used a combination of passive and active surveillance to better detect exposure to RSV infection in a population-based birth cohort study, which found that not being infected with RSV in the first year of life was associated with a 26% reduced risk of 5-year current asthma among healthy children born at term.
[Correspondence] The INSPIRE study: RSV infection during infancy
thelancet.com
The INSPIRE study by Christian Rosas-Salazar and colleagues1 examines the association between the absence of respiratory syncytial virus (RSV) infection in infancy and the reduced risk of childhood asthma. To ensure exposure during the first RSV season, the study specifically recruited children born between June and December in 2012 and 2013.2 However, the identification of RSV infection in infants was based on two methods: purposeful sampling of nasal wash (38%) for suspected acute respiratory tract infection, or a blood serology test conducted at age 1 year (62%).
[Correspondence] The INSPIRE study: RSV infection during infancy
thelancet.com
The effect of respiratory viral infections (eg, respiratory syncytial virus [RSV] infection, influenza, and COVID-19) in early life on the onset of childhood diseases (eg, asthma, mental health disorders, and childhood cancer) is of great concern globally. However, the challenges facing researchers, paediatricians, and policy makers are a short supply of evidence from well designed observational studies and inconsistent results in randomised controlled trials (RCTs). We were pleased to see that Christian Rosas-Salazar and colleagues1 used a combination of passive and active surveillance to better detect exposure to RSV infection in a population-based birth cohort study, which found that not being infected with RSV in the first year of life was associated with a 26% reduced risk of 5-year current asthma among healthy children born at term.

Log in met Medi-Access om meer nieuws te zien

Inloggen Aanmelden